Literature DB >> 9780194

IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12.

K F Hoffmann1, P Caspar, A W Cheever, T A Wynn.   

Abstract

The development of hepatic fibrosis and portal hypertension is the principal cause of morbidity and mortality in schistosomiasis mansoni. Nevertheless, relatively little is known about the mechanisms that lead to excessive collagen deposition during infection with Schistosoma mansoni. In the murine model, infection leads to significant egg-induced granuloma formation, tissue eosinophilia, and hepatic fibrosis. The pathology has been linked to dominant type 2 cytokine expression, and our recent studies showed that sensitizing animals to egg Ags in combination with IL-12, before infection, led to a highly significant reduction in egg-induced immunopathology. In this study, we demonstrate that in contrast with egg/IL-12-sensitized animals that showed marked decreases in pathology, mice similarly sensitized but depleted of IFN-gamma, IL-12, or TNF-alpha at the time of egg laying developed granulomas that were similar to the non-IL-12-treated control group. Although all three anti-cytokine-treated groups exhibited a dominant type 1 response in lymph node cells restimulated ex vivo, the expression of type 2 cytokine mRNA was markedly restored at the site of granuloma formation, which suggests that all three cytokines are required to maintain the suppressed type 2 pattern. Moreover, egg/IL-12-sensitized mice depleted of IFN-gamma or IL-12 displayed a partial reduction in IFN-gamma production, suggesting that multiple type 1 cytokines were required to maintain polarized type 1 responses to chronic type 2-inducing stimuli. Together, these data reveal key roles for IFN-gamma, IL-12, and TNF-alpha in the protective effects mediated by this IL-12-based vaccine to prevent pathology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Immunology of parasitic helminth infections.

Authors:  Andrew S MacDonald; Maria Ilma Araujo; Edward J Pearce
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

3.  The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancer.

Authors:  Sujit S Nair; Anitha Bommana; Jeffrey M Bethony; Amanda J Lyon; Kazufumi Ohshiro; Suresh B Pakala; Gabriel Rinaldi; Brian Keegan; Sutas Suttiprapa; Maria V Periago; Peter J Hotez; Paul J Brindley; Rakesh Kumar
Journal:  Hepatology       Date:  2011-06-08       Impact factor: 17.425

4.  Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin.

Authors:  Nagwa Mostafa El-Sayed; Ghada Mahmoud Fathy; Sara Abdel-Rahman Abdel-Rahman; Mahmoud Abdel-Atei El-Shafei
Journal:  J Parasit Dis       Date:  2014-10-30

5.  Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo.

Authors:  M K Park; K F Hoffmann; A W Cheever; D Amichay; T A Wynn; J M Farber
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.

Authors:  M Hesse; A W Cheever; D Jankovic; T A Wynn
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

8.  Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

Authors:  Ping Liu; Yi-Yang Hu; Cheng Liu; Da-Yuan Zhu; Hui-Ming Xue; Zhi-Qiang Xu; Lie-Ming Xu; Cheng-Hai Liu; Hong-Tu Gu; Zhi-Qing Zhang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Granulomatous transformation of capillary lesions in pulmonary-renal syndrome autologously induced anti-glomerular basement membrane disease in Wistar-Kyoto rats.

Authors:  Daiju Aoyagi; Koh Nakazawa; Tomoki Kaneyama; Junya Masumoto; Masako Otani; Hidekazu Shigematsu
Journal:  Clin Exp Nephrol       Date:  2010-01-09       Impact factor: 2.801

10.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.